Patent · US Active

Anti-pulmonary tuberculosis nitroimidazole derivative

US10227362B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 28, 2016
Grant dateMar 12, 2019
Priority date
Expiry dateJan 28, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.